Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.18632/oncotarget.15470

http://scihub22266oqcxt.onion/10.18632/oncotarget.15470
suck pdf from google scholar
C5400560!5400560 !28423497
unlimited free pdf from europmc28423497
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid28423497
      Oncotarget 2017 ; 8 (13 ): 20988-21000
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function #MMPMID28423497
  • Zhao C ; Chen Z ; Qi J ; Duan S ; Huang Z ; Zhang C ; Wu L ; Zeng M ; Zhang B ; Wang N ; Mao H ; Zhang A ; Xing C ; Yuan Y
  • Oncotarget 2017[Mar]; 8 (13 ): 20988-21000 PMID28423497 show ga
  • Cisplatin chemotherapy often causes acute kidney injury (AKI) in cancer patients. There is increasing evidence that mitochondrial dysfunction plays an important role in cisplatin-induced nephrotoxicity. Degradation of damaged mitochondria is carried out by mitophagy. Although mitophagy is considered of particular importance in protecting against AKI, little is known of the precise role of mitophagy and its molecular mechanisms during cisplatin-induced nephrotoxicity. Also, evidence that activation of mitophagy improved mitochondrial function is lacking. Furthermore, several evidences have shown that mitochondrial fission coordinates with mitophagy. The aim of this study was to investigate whether activation of mitophagy protects against mitochondrial dysfunction and renal proximal tubular cells injury during cisplatin treatment. The effect of mitochondrial fission on mitophagy was also investigated. In cultured human renal proximal tubular cells, we observed that 3-methyladenine, a pharmacological inhibitor of autophagy, blocked mitophagy and exacerbated cisplatin-induced mitochondrial dysfunction and cells injury. In contrast, autophagy activator rapamycin enhanced mitophagy and protected against the harmful effects of cisplatin on mitochondrial function and cells viability. Suppression of mitochondrial fission by knockdown of its main regulator dynamin-related protein-1 (Drp1) decreased cisplatin-induced mitophagy. Meanwhile, Drp1 suppression protected against cisplatin-induced cells injury by inhibiting mitochondrial dysfunction. Our results provide evidence that Drp1-depedent mitophagy has potential as renoprotective targets for the treatment of cisplatin-induced AKI.
  • |Acute Kidney Injury/metabolism/pathology/*prevention & control [MESH]
  • |Antineoplastic Agents/adverse effects [MESH]
  • |Apoptosis/*drug effects [MESH]
  • |Autophagy/drug effects [MESH]
  • |Cell Proliferation/drug effects [MESH]
  • |Cells, Cultured [MESH]
  • |Cisplatin/*adverse effects [MESH]
  • |Dynamins [MESH]
  • |Epithelial Cells/drug effects/metabolism/*pathology [MESH]
  • |GTP Phosphohydrolases/*metabolism [MESH]
  • |Humans [MESH]
  • |Kidney Tubules/drug effects/metabolism/*pathology [MESH]
  • |Microtubule-Associated Proteins/*metabolism [MESH]
  • |Mitochondria/drug effects/metabolism/*pathology [MESH]
  • |Mitochondrial Proteins/*metabolism [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box